WANGSU SCIENCE & TECHNOLOGY CO.,LTD. Financials Wangsu Science & Technology Co.,Ltd.
Equities
300017
CNE100000GQ8
IT Services & Consulting
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.28 CNY | +2.10% |
|
+1.35% | +5.48% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 23,129 | 16,845 | 16,316 | 13,536 | 18,998 | 20,068 | - | - |
| Enterprise Value (EV) 1 | 21,618 | 15,939 | 15,827 | 11,233 | 17,269 | 15,839 | 17,243 | 15,694 |
| P/E ratio | 953 x | 76.6 x | 95.6 x | 69.8 x | 31.4 x | 31.2 x | 30.1 x | 22.6 x |
| Yield | 0.31% | 0.15% | 0.45% | 0.9% | 3.18% | 1.68% | 1.56% | 3.22% |
| Capitalization / Revenue | 3.85 x | 2.96 x | 3.57 x | 2.66 x | 4.04 x | 4.04 x | 3.65 x | 3.54 x |
| EV / Revenue | 3.6 x | 2.8 x | 3.46 x | 2.21 x | 3.67 x | 3.19 x | 3.13 x | 2.77 x |
| EV / EBITDA | 29 x | 19 x | 23.7 x | 16.9 x | 16.8 x | 21.1 x | 20.1 x | 14.9 x |
| EV / FCF | -142 x | 35.9 x | 25.3 x | - | 24.3 x | 64.6 x | 65.3 x | - |
| FCF Yield | -0.7% | 2.78% | 3.96% | - | 4.11% | 1.55% | 1.53% | - |
| Price to Book | 2.69 x | 1.94 x | 1.85 x | 1.51 x | 1.99 x | 2.06 x | 1.99 x | 1.89 x |
| Nbr of stocks (in thousands) | 2,426,999 | 2,444,890 | 2,438,907 | 2,425,840 | 2,420,144 | 2,423,732 | - | - |
| Reference price 2 | 9.530 | 6.890 | 6.690 | 5.580 | 7.850 | 8.280 | 8.280 | 8.280 |
| Announcement Date | 2/28/20 | 3/30/21 | 4/22/22 | 4/19/23 | 4/12/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6,007 | 5,687 | 4,575 | 5,084 | 4,705 | 4,972 | 5,506 | 5,667 |
| EBITDA 1 | 745.4 | 838.9 | 667.6 | 663.8 | 1,026 | 751.2 | 856.7 | 1,051 |
| EBIT 1 | 164 | 289.6 | 173 | 255.3 | 685.4 | 705.6 | 838.4 | 978.6 |
| Operating Margin | 2.73% | 5.09% | 3.78% | 5.02% | 14.57% | 14.19% | 15.23% | 17.27% |
| Earnings before Tax (EBT) 1 | 21.67 | 218.3 | 137.7 | 194.1 | 651.4 | 595 | 705.2 | 934 |
| Net income 1 | 34.48 | 220 | 165.2 | 190.6 | 613.1 | 648 | 671.5 | 894.1 |
| Net margin | 0.57% | 3.87% | 3.61% | 3.75% | 13.03% | 13.03% | 12.2% | 15.78% |
| EPS 2 | 0.0100 | 0.0900 | 0.0700 | 0.0800 | 0.2500 | 0.2650 | 0.2751 | 0.3667 |
| Free Cash Flow 1 | -151.8 | 443.4 | 626.2 | - | 709.6 | 245 | 264 | - |
| FCF margin | -2.53% | 7.8% | 13.69% | - | 15.08% | 4.93% | 4.8% | - |
| FCF Conversion (EBITDA) | - | 52.86% | 93.8% | - | 69.15% | 32.62% | 30.82% | - |
| FCF Conversion (Net income) | - | 201.56% | 378.96% | - | 115.74% | 37.81% | 39.32% | - |
| Dividend per Share 2 | 0.0300 | 0.0100 | 0.0300 | 0.0500 | 0.2500 | 0.1392 | 0.1289 | 0.2667 |
| Announcement Date | 2/28/20 | 3/30/21 | 4/22/22 | 4/19/23 | 4/12/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,325 | - | 1,302 | 1,203 | 1,347 | - | - | 1,191 | 1,188 | 1,120 | 1,491 | 1,378 | 1,542 |
| EBITDA | 85.58 | - | 91.72 | 141 | - | - | - | - | - | - | - | - | - |
| EBIT | 35.95 | - | 37.01 | 106.6 | 64.64 | - | - | 184.6 | 195.4 | - | - | - | - |
| Operating Margin | 2.71% | - | 2.84% | 8.86% | 4.8% | - | - | 15.51% | 16.44% | - | - | - | - |
| Earnings before Tax (EBT) | -2.269 | - | 35.68 | 90.7 | - | - | - | 173.5 | 194.8 | - | - | - | - |
| Net income | 23.99 | - | 35.4 | 88.33 | - | - | - | 167.5 | 187.4 | - | - | - | - |
| Net margin | 1.81% | - | 2.72% | 7.34% | - | - | - | 14.07% | 15.77% | - | - | - | - |
| EPS 2 | 0.0100 | 0.0211 | 0.0200 | 0.0300 | 0.0100 | 0.0391 | 0.0700 | 0.0600 | 0.0800 | 0.0567 | 0.0200 | 0.0300 | 0.0300 |
| Dividend per Share | 0.0300 | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 4/22/22 | 4/28/22 | 8/19/22 | 10/26/22 | 4/19/23 | 4/27/23 | 8/23/23 | 10/24/23 | 4/12/24 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 1,511 | 907 | 490 | 2,303 | 1,729 | 4,230 | 2,826 | 4,374 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -152 | 443 | 626 | - | 710 | 245 | 264 | - |
| ROE (net income / shareholders' equity) | 0.4% | 2.54% | 1.89% | 2.12% | 6.58% | 6.17% | 6.66% | 8.09% |
| ROA (Net income/ Total Assets) | 0.31% | 2.15% | 1.59% | 1.67% | 5.85% | 5.95% | 5.75% | 7.57% |
| Assets 1 | 11,124 | 10,247 | 10,367 | 11,428 | 10,479 | 10,892 | 11,685 | 11,819 |
| Book Value Per Share 2 | 3.550 | 3.540 | 3.610 | 3.700 | 3.950 | 4.030 | 4.160 | 4.380 |
| Cash Flow per Share 2 | 0.2500 | 0.3300 | 0.3400 | 0.3800 | 0.3200 | 0.3000 | 0.3200 | 0.4200 |
| Capex 1 | 762 | 354 | 255 | 178 | 86.7 | 423 | 441 | 34 |
| Capex / Sales | 12.69% | 6.23% | 5.57% | 3.49% | 1.84% | 8.51% | 8% | 0.6% |
| Announcement Date | 2/28/20 | 3/30/21 | 4/22/22 | 4/19/23 | 4/12/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
8.28
CNY
Average target price
9.37
CNY
Spread / Average Target
+13.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.48% | 2.77B | |
| -19.53% | 177B | |
| -3.23% | 159B | |
| +2.05% | 153B | |
| +5.13% | 100B | |
| +9.84% | 81.11B | |
| +22.85% | 75.87B | |
| -8.81% | 69.81B | |
| -31.57% | 45.63B | |
| -9.69% | 42.96B |
- Stock Market
- Equities
- 300017 Stock
- Financials Wangsu Science & Technology Co.,Ltd.
